Our 2024 Toward Health Equity Oncology Grant focuses on inclusion in trials and supports the mission of 36 global organizations centered on a common goal: providing quality, accessible healthcare for people living with cancer. Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need.